Clinical Trial

Introducing Electronic Alerts to Reduce Inappropriate Digoxin Prescribing in Older Adults

Study acronym: Aldigo
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The intervention consists of introducing computerized alerts into the electronic medical record of the CSAPG (MIRA software), which are triggered when a physician prescribes digoxin at a dose higher than the recommended amount (more than 0.125 mg/day). The main objective of this study is to evaluate the effectiveness of a visible computerized alert aimed at physicians responsible for hospitalized elderly patients who have been prescribed digoxin at a dose higher than 0.125 mg/day (the recommended dose), in reducing the number of patients receiving inappropriate digoxin doses.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-04.
Trial Details
NCT Number NCT07008144
Lead Sponsor Consorci Sanitari de l'Alt Penedès i Garraf
Conditions Drug-Related Side Effects and Adverse Reaction, Digoxin Overdose
Enrollment 5,954 participants
Start Date 2025-12
Primary Completion 2026-11-30 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-02